BMC Biology is calling for submissions to our Collection on Cancer metabolism. Cancer metabolism is a developing field that explores the biochemical and physiological changes that occur in cancer cells, which often exhibit distinct metabolic pathways compared to normal cells. Alterations such as the Warburg effect, where cancer cells preferentially utilize glycolysis for energy production even in the presence of oxygen, play a pivotal role in tumor progression and survival. Understanding the intricacies of cancer metabolism provides insights into how tumors adapt to their microenvironments and highlights potential therapeutic targets for intervention.

Future research in cancer metabolism promises to yield transformative insights that could reshape therapeutic approaches and improve precision medicine. The continued focus on metabolic pathways may lead to the identification of new biomarkers for cancer diagnosis and prognosis, as well as novel strategies to enhance the sensitivity of cancer cells to treatment. As we deepen our understanding of the metabolic landscape of tumors, we may uncover innovative strategies that exploit these vulnerabilities, ultimately leading to novel and more effective cancer treatments, as well as improved patient outcomes.

Recent advancements in the field, including the identification of metabolic reprogramming strategies and the influence of diet on tumor growth, have opened new avenues for research. Investigations into the roles of lipids, fatty acids, and dietary interventions, such as ketogenic diets, are revealing potential methods for manipulating tumor metabolism and enhancing the efficacy of existing treatments. We invite researchers to submit their work to this Collection, which aims to showcase groundbreaking research and technologies addressing cancer metabolism and support the advancement of this field, encompassing a wide array of topics related to metabolic pathways and their implications for cancer biology and therapy.

Potential topics include but are not limited to:

• Metabolic reprogramming in cancer cells
• The Warburg effect and its implications
• Role of mitochondria in cancer metabolism
• Impact of dietary interventions on tumor metabolism
• Glycolysis and lipid metabolism in cancer
• Animal models
• Imaging and method developments
• Metabolic engineering

This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being).

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

BMC Biology is calling for submissions to our Collection on the biology of neurodegenerative diseases. This Collection aims to bring together multidisciplinary knowledge to better understand the mechanisms driving progressive neuronal dysfunction and loss.

We welcome studies investigating key pathological mechanisms, including protein misfolding and aggregation, neuroinflammation, oxidative stress, mitochondrial disorders, dysfunction of cellular protein sorting and degradation, altered RNA metabolism, blood-brain barrier impairment, brain vascular dysfunction, contribution of extracellular vesicles and synaptic dysfunction. Research exploring intracellular transport disruptions, neuronal network alterations, and genetic or epigenetic contributions to neurodegeneration is also encouraged.

We are particularly seeking submissions that employ state-of-the-art approaches, such as multi-omics, electrophysiology, high-resolution imaging, (induced) pluripotent stem cell-derived model systems, (e.g. microfluidics 2D co-culture, organoids and assembloids), and animal models to gain deeper mechanistic insights into neurodegenerative processes and identify potential therapeutic targets.

This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.